Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 4, 2017 9:01:10 GMT -5
Sirius radio founded in 1990 went up to $69 a share and then down to $0.05 on 02.11.2009 due to the same stubborn articles written by Spencer Osborn and commented in the cheering fashion by the same kind of admiring idiots like risingsceptisism, trend, najak and on and on. Sirius in early Febuary announced to go bankrupt on 02.17.2009. On the same day Liberty Media bought 40% of shares for $550,000 and we know the rest. Tesla today is continueing loosing money from the vary start in 2010 at $17 till today at $297. "When I hear the word culture I reach for my gun." Hermann Goring I would like to paraphrase this quote by replacing culture with the bloody PROFIT. You're comparing Matt Pfeffer to Mel Karmazin and Elon Musk, he's not even close to being in the same league. Matt absolutely has no vision or any CEO experience close to Mel and Elon to drive this company to a success level that the latter 2 have done. It's like comparing a Bicycle to a Lambo. |
|
|
|
Post by deanbain on Apr 4, 2017 9:04:04 GMT -5
Someone please tell me what PWD means
|
|
|
|
Post by sportsrancho on Apr 4, 2017 9:06:27 GMT -5
|
|
|
|
Post by sla55 on Apr 4, 2017 9:10:20 GMT -5
Someone please tell me what PWD means PWD: Persons with Disabilities |
|
|
|
Post by sportsrancho on Apr 4, 2017 9:11:08 GMT -5
Someone please tell me what PWD means PWD: Persons with Disabilities Person with diabetes |
|
|
|
Post by sla55 on Apr 4, 2017 9:11:55 GMT -5
PWD: Persons with Disabilities Person with diabetes Sorry! More like it. Thanks! |
|
|
|
Post by tw12 on Apr 4, 2017 9:13:37 GMT -5
This thread is like a locker room after a big loss. Towels thrown in, down, all over the place.
Yet MannKind remains so much more than it's assaulted stock price. Afrezza is unique and works spectacularly well; it has a huge, worldwide market; there are other intriguing paths for Technosphere; and there is enough financing for the next five months. Thanks to all the good folks who continue to work hard and well day after day in Valencia and Danbury, there is a solid momentum towards MannKind's ultimate success - only much of it, granted, is behind the scenes or below the radar.
By the way, along those lines, the TV ads are testing well (I was at the agency last week) and will feature the power of direct witnessing by Afrezza users, not simply the Outsulin and Insulin characters.
|
|
|
|
Post by careful2invest on Apr 4, 2017 9:31:25 GMT -5
Sirius radio founded in 1990 went up to $69 a share and then down to $0.05 on 02.11.2009 due to the same stubborn articles written by Spencer Osborn and commented in the cheering fashion by the same kind of admiring idiots like risingsceptisism, trend, najak and on and on. Sirius in early Febuary announced to go bankrupt on 02.17.2009. On the same day Liberty Media bought 40% of shares for $550,000 and we know the rest. Tesla today is continueing loosing money from the vary start in 2010 at $17 till today at $297. "When I hear the word culture I reach for my gun." Hermann Goring I would like to paraphrase this quote by replacing culture with the bloody PROFIT. Exactly!! Spencer and his cronies are relentless. The only people that still waste their time responding to his "articles" are shorts just like him! Maybe I am inhaleing too much hopium, but I still have hope and believe that we can get through this! Many parts are in alignment for AFREZZA to ultimately become successful. Time will tell! GLTA TRUE LONGS! |
|
|
|
Post by orlon on Apr 4, 2017 10:03:46 GMT -5
What the hell is a Global People Officer? How do I get a job with that title for 365k? Can I work from home?
|
|
|
|
Post by slugworth008 on Apr 4, 2017 10:19:56 GMT -5
PWD: Persons with Disabilities Person with diabetes Primary WhaaatsAfrezza Doctor - Sorry Sports I couldn't hep myself. |
|
|
|
Post by sweedee79 on Apr 4, 2017 11:41:55 GMT -5
I does work ... but if docs aren't that receptive and not prescribing it as they should be it creates failure... For us we had to discontinue use because the docs weren't very cooperative .. wouldn't raise the dose as needed .. and insurance refused to pay .. As some have pointed out here it takes quite a lot more Afrezza in order to get the success we have seen..
I don't care who buys it... its an amazing insulin.. that is a fact and this is so sad ..
Docs wouldn't raise the dose? No... they prescribed to my dad the same unit for unit as he had been on with Novolog. The label says that they are the same dose for dose. I pushed for a higher a dose but the docs were afraid of hypo even tho my dad never goes hypo even on Novolog. My dads A1C turned out to be about the same as it had been on injectable, however he lost a lot of weight and he felt so much better. His final A1C was around 6.6 on Afrezza if I remember right.... but he was watching his diet very carefully and exercising which I don't think he was doing so much on Novolog. The truth about Afrezza is that you can take more of it without as much concern about going hypo ... and get better control.
I believe Afrezza is ahead of its time or something... not sure.. and the trial data we have didn't support superiority... nor does the label give us the freedom to say what Afrezza really is... or how to dose.. I have said this from the beginning...
But to say it doesn't work is completely false.. it is the hands down the best insulin on the market.
|
|
|
|
Post by agedhippie on Apr 4, 2017 12:12:04 GMT -5
Docs wouldn't raise the dose? No... they prescribed to my dad the same unit for unit as he had been on with Novolog. The label says that they are the same dose for dose. I pushed for a higher a dose but the docs were afraid of hypo even tho my dad never goes hypo even on Novolog. My dads A1C turned out to be about the same as it had been on injectable, however he lost a lot of weight and he felt so much better. His final A1C was around 6.6 on Afrezza if I remember right.... but he was watching his diet very carefully and exercising which I don't think he was doing so much on Novolog. The truth about Afrezza is that you can take more of it without as much concern about going hypo ... and get better control.
I believe Afrezza is ahead of its time or something... not sure.. and the trial data we have didn't support superiority... nor does the label give us the freedom to say what Afrezza really is... or how to dose.. I have said this from the beginning...
But to say it doesn't work is completely false.. it is the hands down the best insulin on the market.
Was he open to increasing the dose without the doctor's agreement? Most diabetics modify their insulin requirements on the fly (I need more in summer than winter for example) but just do it and don't talk to their doctor. I would be more of a problem if he wasn't getting sufficient Afrezza to do that though. I know I have an insulin stockpile so if I was in his position I could carry on with Novolog from the stock pile for a couple of months while stashing away Afrezza. That then gives him the Afrezza he needs to get results to argue requirements. Of course this is probably no use because of the insurance problem, but it's a thought if that ever resolves. |
|
|
|
Post by dreamboatcruise on Apr 4, 2017 12:25:45 GMT -5
Looks bad. Agreed. Too bad the insulin works so well. If it worked that well you would see a significant number of refills. I do not buy that people do not refill due to price. Who would fill a script if they knew they couldn't afford to refill it? The reality is, not many are having success with Afrezza that we thought we'd see. Even management has admitted this is a problem, so it would be crazy to try to deny that it has been. Hopefully they gotten a handle on this. Just this weekend I got my own little reminder of this issue. Chatting at a hotel bar with someone that worked for a medical group in CA, whose spouse did lobbying for medical device companies. I ended up mentioning Minimed and then Mannkind and "inhaled insulin". The response I got on "inhaled insulin" based on their own experience prescribing inhaled insulin was... "it works for some, but it doesn't work for many". It will be a slow climb out of this since negative views will take time to turn around. |
|
|
|
Post by slugworth008 on Apr 4, 2017 12:33:05 GMT -5
If it worked that well you would see a significant number of refills. I do not buy that people do not refill due to price. Who would fill a script if they knew they couldn't afford to refill it? The reality is, not many are having success with Afrezza that we thought we'd see. Even management has admitted this is a problem, so it would be crazy to try to deny that it has been. Hopefully they gotten a handle on this. Just this weekend I got my own little reminder of this issue. Chatting at a hotel bar with someone that worked for a medical group in CA, whose spouse did lobbying for medical device companies. I ended up mentioning Minimed and then Mannkind and "inhaled insulin". The response I got on "inhaled insulin" based on their own experience prescribing inhaled insulin was... "it works for some, but it doesn't work for many". It will be a slow climb out of this since negative views will take time to turn around. The real questions is at this point - IMO - Is...will/would meaningful DTC overcome this or expedite changing negative views??? |
|
|
|
Post by dreamboatcruise on Apr 4, 2017 12:38:32 GMT -5
Even management has admitted this is a problem, so it would be crazy to try to deny that it has been. Hopefully they gotten a handle on this. Just this weekend I got my own little reminder of this issue. Chatting at a hotel bar with someone that worked for a medical group in CA, whose spouse did lobbying for medical device companies. I ended up mentioning Minimed and then Mannkind and "inhaled insulin". The response I got on "inhaled insulin" based on their own experience prescribing inhaled insulin was... "it works for some, but it doesn't work for many". It will be a slow climb out of this since negative views will take time to turn around. The real questions is at this point - IMO - Is...will/would meaningful DTC overcome this or expedite changing negative views??? I would suspect that management has felt the answer is NO and that is why DTC has been slow to come. Probably been trying to show docs that MNKD now has the support in place to make onboarding successful and demonstrate that with a few patients before unleashing a bunch of patients from DTC "ask your doctor". |
|
